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ABSTRACT
Aptamers are nucleic acids developed by in vitro
evolution techniques that bind to specific ligands
with high affinity and selectivity. Despite such high
affinity and selectivity, however, in vitro evolution
does not necessarily reveal the minimum structure
of the nucleic acid required for selective ligand bind-
ing. Here, we show that a 35mer RNA aptamer for the
cofactor flavin mononucleotide (FMN) identified by
in vitro evolution can be computationally evolved to
a mere 14mer structure containing the original bind-
ing pocket and eight scaffolding nucleotides while
maintaining its ability to bind in vitro selectively to
FMN. Using experimental and computational meth-
odologies, we found that the 14mer binds with higher
affinity to FMN (KD   4 mM) than to flavin adenine
dinucleotide(KD 12mM)ortoriboflavin(KD 13mM),
despite the negative charge of FMN. Different
hydrogen-bond strengths resulting from differing
ring-system electron densities associated with the
aliphatic-chain charges appear to contribute to the
selectivity observed for the binding of the 14mer to
FMN and riboflavin. Our results suggest that high
affinity and selectivity in ligand binding is not
restricted to large RNAs, but can also be a property
of extraordinarily short RNAs.
INTRODUCTION
Aptamers can be exploited for their selective ligand binding.
Among the numerous types (1) of ligands for which RNA
aptamers have been selected are ﬂat, aromatic compounds,
including ﬂavin mononucleotide (FMN) (2,3). Aptamers are
not useful merely as passive ligand binders, but can play active
roles in gene regulation. Riboswitches, for example, are
elements in certain mRNAs that regulate gene expression
by acting as receptors for speciﬁc metabolites (4–6).
Riboswitches regulate metabolic pathways for the biosyn-
thesis of a variety of important molecules (7,8), including
the cofactor FMN (4,5,9), which mediates oxidation-
reductionreactionswhenboundtoﬂavoproteinsasaprosthetic
group. Riboswitches usually contain a ligand-binding
(aptamer) domain and a downstream region whose conforma-
tion is able to permit or repress gene expression (10,11). The
aptamer domains of riboswitches are similar to aptamers
developed by in vitro techniques (12–16) in that they bind
their ligands with exquisite afﬁnity and selectivity (7,8).
For instance, the FMN riboswitch (4,5,9) is able to discrimi-
nate against riboﬂavin (Figure 1A) by three orders of magni-
tude with respect to FMN (Figure 1B), despite the negative
charge of FMN (5). In addition, recent studies have demon-
strated that synthetic aptamers for small molecules can also be
inserted into the 50-UTR region of mRNA in vitro and in vivo,
signiﬁcantly reducing mRNA translation upon ligand addition
(17,18). Other examples of aptamer uses for gene regulation
include engineered RNA switch systems that act as ligand-
responsive riboregulators (19–21), which have recently been
reviewed (22).
Determining the minimum sequence requirements of
aptamers for selective ligand binding can allow the design
of structures that are less likely to get trapped in energetically
favorable inactive conformations (23,24). The notion of ‘con-
formational hell’ can be an issue of concern, as, according to
theoretical models, both the mean and maximum barrier
heights for a given RNA sequence scale with sequence length
N roughly as N
1/2 (25). Moreover, the number of competing
minima, in which the RNA can form inactive metastable struc-
tures, swells with increasing sequence size (26,27).
From this standpoint, it may be fortunate, then, that the ﬁnal
aptamer nucleotide sequences that are obtained from in vitro
evolution techniques are not necessarily the minimum
sequences necessary for the aptamers to perform their func-
tions (13,28). The in vitro selection methodology requires the
use of many randomized nucleotide positions in the primary
structures of nucleic acid libraries, and consequently the
ﬁnal evolved structures usually contain unnecessary stretches
of nucleotides. At present, there are several experimental
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aptamer. These protocols include (i) decreasing the size of
the randomized region until there remains no more afﬁnity
selection (28), (ii) random terminal truncation experiments
(29), (iii) minimization using random internal deletions (30)
and (iv) selection from remutagenized pools (31). We have
recently predicted computationally and shown experimentally
(32) that a 33mer RNA aptamer for theophylline (33) can be
truncated to a 13mer structure containing only seven binding-
pocket and six scaffolding nucleotides from the original
33mer while maintaining its ability to bind selectively to
theophylline. This ﬁnding suggests that, in certain cases,
large stretches of primary structure may potentially be
removed from aptamers without compromising the aptamers’
functions.
We have developed an iterative computational approach to
determine the shortest truncated structure of the FMN-binding
35mer RNA (2,3).This approach may serve as a supplement to
the extensive experimental protocols that are currently relied
upon for identifying minimum structure requirements for
selective ligand binding. The 35mer which we used as a
model for our methodology binds to FMN with KD ¼ 500 nM
and to ﬂavin adenine dinucleotide (FAD) (Figure 1C) with
KD ¼ 700 nM (2). We have applied our computational
methodology to show that a 14mer RNA containing only
six binding-pocket nucleotides and eight additional scaffold-
ing nucleotides from the original 35mer is able to bind FMN.
The 14mer is able to discriminate against the structurally
similar compound riboﬂavin and also against FAD. In addi-
tion, we have investigated the preference of the polyanionic
RNA molecule for negatively charged FMN over neutral
riboﬂavin using density functional theory (DFT) calculations.
We observed that signiﬁcantly different hydrogen-bonding
strengths of FMN and riboﬂavin complexed with an adenine
residue in the binding pocket are consistent with the difference
between binding energies and with the aptamer’s preferential
binding to FMN.
MATERIALS AND METHODS
In vitro nucleic acids
RNA and DNA oligomers were purchased from Integrated
DNA Technologies (Coralville, IA). The original 35mer
RNA aptamer sequence was transcribed from a 52 nt antisense
DNA containing a 17 nt promoter using T7 polymerase.
Computational design of 14mer RNA
The NMR structure of the 35mer RNA complexed with FMN
was loaded from the PDB (PDB code 1FMN) into the Macro-
Model version 7.0 software package (34). The ﬁrst NMR
structure was selected. Nucleotide pairs that appeared quali-
tatively to be unnecessary for FMN binding were deleted from
the RNA, beginning at the 50 and 30 ends. The farther a nuc-
leotide pair was located from the binding pocket, the more
suitable it was considered for deletion. The ﬁrst deletion con-
sisted of nucleotides G1 to G6 and A31 to C35. An energy
minimization was performed on the modiﬁed structure using
500 steps of steepest descent followed by Polak-Ribiere con-
jugate gradient minimization until convergence of the gradient
(0.01 kJ/mol s) was reached using the AMBER force ﬁeld
(35) and a generalized Born/solvent-accessible surface area
(GB/SA) implicit water solvent model (36) with a dielectric
constant of 78. A 500 ps molecular dynamics (MD) simulation
at 300 K using the same force ﬁeld and implicit-solvent model
and 1 fs time steps was then performed on the minimized
structure. The FMN was predicted to remain bound and the
binding-pocket structure was not perturbed. Individual base
pairs were subsequently excised one by one from the newest
50 and 30 ends resulting from the previous truncations, with
eachnewstructureundergoingenergyminimizationand500ps
of molecular dynamics as described above. This stepwise
removal of base pairs was continued until the remaining
RNA structure was sufﬁciently short that the binding pocket
was shown to open up and become entirely solvent exposed
during the course of the MD simulation. The 14mer was the
shortest structure that maintained integrity of the binding
pocket and a tight ligand-pocket ﬁt. Deletions of either the
A4-G11 base pair or the C5-G10 base pair of the 14mer
resulted in RNA structures that lost intrastrand stabilization
and signiﬁcant disruption of the binding pocket’s structure.
Explicit-solvent MD simulation of 14mer:FMN complex
The 14mer RNA structure identiﬁed above was loaded into the
AMBER 7 suite of programs [(37) AMBER 7, University of
California, San Francisco] and solvated in a 54 s · 63 s ·
54 s orthorhombic box containing  4250 TIP3P (38) water
molecules. Twelve Na
+ counterions were added automatically
to regions of greatest electrostatic potential in order to achieve
a neutral system charge. Employing the ff02 force ﬁeld (39) for
RNA and the gaff force ﬁeld (40) for FMN, the water mole-
cules and solute were relaxed with ﬁve separate energy-
minimization runs, each of which consisted of 500 steepest-
descent steps followed by 2000 conjugate-gradient steps. Har-
monic restraints on all solute (RNA and FMN) atoms
decreased gradually from 500 kcal mol
 1 s
 2 to zero over
the ﬁve separate minimizations. The system was then equili-
brated to 300 K and 1 g/ml density by heating from 100 to 300
K over the course of 60 ps using 2 fs time steps, an 11 s
Figure 1. Ligand structures for FMN aptamer and riboswitch. (A) Riboflavin.
(B) FMN. (C) FAD.
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of long-range electrostatic interactions. All covalent bonds
containing hydrogen were constrained by the SHAKE algo-
rithm (42), and the system temperature was controlled by
coupling to an external bath using the Berendsen method
(43). Following equilibration, a production run of 3 ns was
performed at 300 K using the same simulation conditions.
In vitro binding assays
All ﬂuorescence measurements (lexcitation ¼ 445 nm,
lemission ¼ 525 nm) were performed on a Hitachi F-3010 ﬂuo-
rimeter at 295 K. For both the 14mer, the 35mer and the ﬁrst
non-binding RNA (12mer) aptamers, a solution of 1 mM FMN
was prepared in a buffer containing 100 mM HEPES, 50 mM
NaCl and 10 mM MgCl2. In the case of FAD and riboﬂavin
binding, solutions of 1 mM FAD and 1 mM riboﬂavin in the
same HEPES buffer were used. Binding constants were mea-
sured by observing the quenching of ligand ﬂuorescence by
bound RNA. Aliquots of each RNA were successively added
to the FMN, FAD and riboﬂavin solutions to yield increasing
total RNA concentrations, and the decreases in ﬂuorescence
intensity as a function of RNA concentration were measured.
The binding isotherms are consistent with the formation of 1:1
complexes. Fluorescence data, after correction for dilution,
were ﬁt to the isotherm (44)
DF ¼
Fo
Kd þ½ L 
using the software package GraphPad Prism4 to yield the
dissociation constant Kd, where DF is the change in FMN,
riboﬂavin or FAD ﬂuorescence upon addition of RNA, [L]
is the RNA concentration at each addition, and Fo is the origi-
nal FMN, riboﬂavin or FAD solution ﬂuorescence.
Ab initio calculations
All calculations were performed using the Gaussian 98 soft-
ware package (45). The riboﬂavin molecule, FMN molecule
and the adenine base were each optimized separately in vacuo
using B3LYP DFT and the 6-31G basis set. In order to
make the optimization of FMN and riboﬂavin more tractable,
the three main dihedral angles of the aliphatic chain in both
molecules were constrained. The optimized FMN and
riboﬂavin structures were each subsequently complexed
with the optimized adenine base, and the complexes optimized
using B3LYP/6-31G and applying the same chain dihedral-
angle constraints as in the optimizations of the separate
molecules. Single-point energy calculations on the optimized
complex structures were performed using B3LYP/
6-31+G(p,d).
RESULTS AND DISCUSSION
Determining shortest RNA that binds FMN
An iterative computational approach was employed to deter-
mine the shortest truncated structure of the original FMN-
binding 35mer RNA that can still bind FMN (Figure 2A).
From the original NMR structure of the 35mer, base pairs
were deleted computationally one or two pairs at a time,
beginning at the 50 and 30 ends. Each separate deletion was
followed by a 500 ps implicit-solvent molecular dynamics
(MD) simulation. This process was repeated until simulations
no longer predicted binding of the ligand. Finally, a 14mer,
predicted as the shortest sequence capable of binding FMN,
was simulated in its complex with FMN using a 3 ns explicit-
solvent molecular dynamics simulation. The FMN remained
bound in the binding pocket over the course of the whole MD
trajectory. The 14mer contains only the original binding pock-
et’s 6 nt and eight additional nucleotides holding the binding
pocket in place (Figure 2B).
MD simulations of sequences containing fewer than eight
scaffolding nucleotides and the six binding-pocket nucleotides
indicate a perturbation of the binding-pocket and overall RNA
structures. The 50 and 30 ends of the RNA dissociate, allowing
increased solvent exposure to FMN. For the 12mer formed by
removal of the A4-G11 base pair of the 14mer, for example,
the backbone stability of the whole RNA is reduced, as shown
by a steadily increasing root-mean-square deviation (RMSD)
of the RNA backbone atoms (C30,C 4 0,C 5 0,O 3 0,O 5 0 and P)
relative to their starting positions as a function of time
Figure2. Secondarystructuresandsurfacerenderingsoforiginalandtruncated
FMN-binding aptamers. Nucleotides of binding pocket are highlighted in red
lettersandFMNisgreen.(A)35merAptamer.(B)14merTruncationof35mer,
retaining six binding-pocket nucleotides (red) and eight additional scaffolding
nucleotides, including the UUCG loop.
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mentof the backbone atoms ofthe 12mer reaches >5s
2 within
3 ns, while that of the 14mer has an average value of only 1.6
s
2andneverexceeds2.5s
2(Figure3B).Figure3AandBalso
illustrates how the 12mer begins to unfold at  2.9 ns.
Furthermore, at  2.2 ns in the 12mer trajectory a signiﬁcant
disruption of the hydrogen bond between the N6 hydrogen
atom of A13 and the O2 carbonyl oxygen atom of FMN is
observed (Figure 3C). Similarly, simulations of 13mers that
contain a single terminal guanine residue at either the 50 or 30
end likewise predict a loss of backbone stability (data not
shown).The 3D structures of the stable 14mer and the unstable
12mer as it begins to unfold are presented in Figure 4. These
observations taken together suggested that the 14mer is the
minimum structure that binds FMN.
The orientation of the FMN ligand in the binding pocket of
the 35mer (Figure 5A) as determined by NMR (3) and that
predicted for the 14mer (Figure 5B) are similar. Both binding
pockets encapsulate the ligand to roughly the same extent. The
NMR structure of the 35mer aptamer shows two hydrogen
bonds formed between the FMN molecule and A26. The
hydrogen-bond lengths and angles for the 14mer complexed
with FMN were calculated at each 1 ps interval of the MD
trajectory. The 14mer is predicted to maintain the same two
hydrogen bonds with FMN over the course of its whole tra-
jectory (Table 1 and Figure 5B). Moreover, the 14mer RNA
exhibits a similar base–ligand–base stacking geometry in the
binding pocket as that in the original aptamer. In the experi-
mental 35mer structure the FMN molecule is sandwiched
between G10, U12 and A25 above and G9 and G27 below,
with  3.4 s separating the planes of each layer’s aromatic
system. In the 14mer average simulation structure, FMN is
sandwiched  4.4 s above and  4.0 s below by the aromatic
systems of the same set of bases.
In vitro study of FMN binding
In order to verify our prediction that the 14mer remains bound
to FMN, we performed an in vitro binding assay of the 14mer
RNA interacting with FMN at 295 K. Fluorescence quenching
of FMN was monitored as a function of RNA concentration in
order to determine the amount of bound FMN. Non-linear
regression of the binding data (Figure 6A) indicates a KD
value of 4.1 ± 1.2 mM, corresponding to a DGassociation of
 31 ± 1 kJ mol
 1. The original 35mer binds FMN with a
KD of  500 nM (2), which corresponds to a DGassociation
Figure 3. Molecular dynamics data suggest stable binding of FMN to 14mer and 14mer RNA stability (left-hand column); 12mer shows structural instability and
inabilitytobindFMN(right-handcolumn).Seetextfordetails.(A)RMSDvaluesofbackboneatom(C30,C4 0,C5 0,O3 0,O5 0,P)positionsrelativetostartingstructure.
(B) Average mean-square displacements of backbone atoms. These values reflect the overall distances over which backbone atoms diffuse. (C) Hydrogen-bond
length (distance between hydrogen atom and acceptor atom) for hydrogen bond between N6 of adenine 13 and carbonyl oxygen atom O2 of FMN.
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 1. Thus, roughly an 8-fold reduction in binding
afﬁnity to FMN occurs in going from the 35mer to the 14mer.
However, the 12mer formed by removal of the A4-G11 base
pair from the 14mer structure showed no ﬂuorescence
quenching even at RNA concentrations as high as 100 mM
(data not shown). This ﬁnding agrees with the prediction by
MD simulations that a major loss of the binding pocket’s
structural integrity accompanies the elimination of the A4-
G11 base pair of the 14mer. The experimental observation
of a discontinuity in the relation between sequence length
and binding energy when making the 14 to 12 nt transition,
and the abrupt fall in binding energy for RNA sequences
shorter than the 14mer suggest that the 14mer is the minimum
sequence necessary for FMN binding.
A binding assay was also performed on the original 35mer
RNA to verify our ﬂuorescence assay methodology (data not
shown). The resulting binding curve indicates a DGassociation of
 37 ± 1 kJ mol
 1, which agrees well with the reported value
of  36 kJ mol
 1.
Selectivity studies
The FMN-binding 35mer aptamer is able to bind FMN (KD ¼
500 nM) while discriminating against FAD (KD ¼ 700 nM).
In order to evaluate the selectivity of the 14mer truncation for
FAD, a binding assay using the same methodology as for the
FMN binding assay was performed. The binding curve
(Figure 6B) and non-linear regression yield a KD value of
12.0 ± 2.0 mM, which corresponds to a DGassociation of
 28 ± 1 kJ mol
 1. Thus, FAD binds to the 14mer roughly
three times more weakly than does FMN.
We next investigated whether the 14mer is able to bind
more tightly to FMN than to riboﬂavin, despite the anionic
character of both FMN and RNA. The binding curve
(Figure 6C) and non-linear regression indicate a KD value
of 12.5 ± 2.7 mM, corresponding to a DGassociation of
 28 ± 1 kJ mol
 1. Thus, riboﬂavin binds to the 14mer
with  3 kJ mol
 1 less energy than does FMN and with the
same afﬁnity as that of FAD. This is not surprising, as the
binding of either FAD or riboﬂavin to the designed 14mer is
Figure 4. Comparisonof predicted 12 and 14mer RNA complex structures. Structures are averages obtained from MD simulations. The top panels show the RNAs
withoutFMN;thebottompanelsshowtheRNAsassurfacerepresentationswiththeligandasatubestructure.(A)The14merformsabindingpocketthatencapsulates
FMNtightlyandshieldsitsflavinringfromcontactwithsolventwatermolecules.(B)The12merlosesstabilitythathadbeenconferredbythethreehydrogenbonds
formedbytheshearedA4·G11N7-amino,amino-N3non-Watson–Crickbasepairofthe14mer.The50 and30 endsoftheRNAbecomeseparated,leavingFMNwith
no hydrogen bonds to the adenine residue A11 (corresponding to A13 of 14mer) and exposed to solvent water molecules.
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bases. The observed selectivity is modest, however, compared
with the  15 kJ mol
 1 energy difference between FMN and
riboﬂavin associating with the FMN-binding riboswitch (5).
The selectivity between FMN and related, neutral ﬂavins is
surprisingconsideringthatanegativelychargedmoleculesuch
as FMN should, in principle, bind less to the polyanionic RNA
than should the corresponding, structurally similar, neutral
molecule riboﬂavin. It has been suggested that the selectivity
of the natural riboswitch may be due to the close proximity
between a cation complexed in the riboswitch and the phos-
phate group of FMN (5). However, this possibility has to be
excluded in the case of the artiﬁcial 14mer aptamer shown
here. This short RNA does not have enough nucleotides to
complex both FMN and a cation such as divalent magnesium.
In the absence of additional interactions that can stabilize the
FMN complex compared with that formed by neutral
riboﬂavin, the selectivity observed for FMN has to be the
result of the effect of the charge of the phosphate ion on
the electronic structure of FMN. In particular, we hypothe-
sized that the electronic density on the phosphate group could
be partially delocalized on the ﬂavin ring and used to
strengthen both the hydrogen bond between carbonyl oxygen
O2 (FMN/riboﬂavin) and the hydrogen on N6 (Adenine 13)
(Figure 5) and p-stacking with the nucleic bases. The former
interaction was estimated with ab initio studies. Density func-
tional ab initio calculations performed on the complexes
FMN/adenine and riboﬂavin/adenine [B3LYP/6-31G//
B3LYP/6-31+G(p,d)] indicate that in the gas phase FMN
binds adenine more favorably than riboﬂavin ( 62 kJ mol
 1
versus  44 kJ mol
 1). While the level and basis sets used in
this calculation reﬂect the large size of the system and the
absolute values of the calculated energies can be improved, the
trend of adenine binding FMN more favorably than the neutral
riboﬂavin is consistent with our experimental observations.
Thus, different hydrogen-bond strengths resulting from
differing ring-system electron densities associated with the
aliphatic-chain charges appear to contribute to the selectivity
observed for the binding of the 14mer to FMN and riboﬂavin.
We have demonstrated that a 35mer RNA aptamer for FMN
can be truncated to a 14mer, a 60% reduction in sequence
size, while losing only 5 kJ mol
 1 of binding energy upon
complex formation. The 14mer contains no more than 6 nt of
the original binding pocket of the 35mer and eight additional
scaffolding nucleotides that are retained from the 35mer.
Figure 5. Binding pocketsand hydrogen bonding in the 35 and 14merRNA aptamers.(A) 35mer Bindingpocket complexed with FMN. (B) 14merBinding pocket
complexed with FMN as predicted by a 3 ns molecular dynamics simulation.
Table 1. Hydrogen-bonding pairs observed in both 35 and 14mer RNA
aptamers complexed with FMN
Simulation
Hydrogen bond Average length (s) Average angle ( )
1 1.96 163
2 2.23 162
Experimental (NMR)
1 2.11 160
2 2.14 136
Hydrogen bonding data for the 35mer are based on the NMR structure (PDB
code 1FMN, first structure). Hydrogen-bonding analysis for the 14mer was
performed using the PTRAJ program of AMBER 7. Cutoff distance between
heavy atoms is 4.0 s. Cutoff donor-hydrogen-acceptor angle is 120 . In both
cases,hydrogenbond1correspondstothatbetweenatomHN3ofFMNandatom
N7ofadenine13(adenine26inthe35mer);hydrogenbond2correspondstothat
between atom O2 of FMN and atom HN6 of adenine 13 (adenine 26 in the
35mer).
Nucleic Acids Research, 2005, Vol. 33, No. 22 6997Removal of merely one additional base pair to form a 12mer,
however, eliminated binding of FMN altogether, indicating
that the 14mer contains no unnecessary structural elements.
Presumably, this ability to maintain binding would hold true
for other aptamer systems involving small, planar aromatic
ligands that are capable of forming stacking interactions with
nucleic acid bases. These ﬁndings suggest that, in principle,
the aptamer region of both natural and artiﬁcially evolved
RNAs can be extraordinarily short while maintaining high
afﬁnity and selectivity. It is interesting to note that the aptamer
binding theophylline—another small, planar aromatic
ligand—which we have studied previously (32) can be trun-
cated to a 13mer and maintain selective ligand binding, and
that any sequences shorter than 13 nt in length abolish binding.
It would appear, then, that 13 to 14 nt may constitute a
sequence-length threshold for short RNAs that selectively
bind and recognize small, planar aromatic molecules. This
size threshold is likely attributable to destabilization of the
folded RNA structure once too few stabilizing intrastrand
hydrogen bonds remain. Furthermore, the fact that the ability
of the original 35mer to bind FMN selectively can be emulated
by a 14mer RNA implies that very short RNAs may also be
able to perform speciﬁc functions in a cellular environment.
The methodology used in the design of the FMN-binding
14mer RNA aptamer can easily be extended to the search for
the minimum sequences of other RNAs that bind to small
molecules. Availability of structural data of the complex
between the small molecule and a larger RNA aptamer is
needed as the starting point of the sequence search. In vitro
evolution of RNA and X-ray- or NMR-based RNA structures
are then indispensable tools for the identiﬁcation of very short
active RNAs.
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